Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Latest Data of InnoCare’s Orelabrutinib Presented at the 17th International Conference on Malignant Lymphoma (ICML)

PharmaSourcesJune 16, 2023

Tag: Orelabrutinib , InnoCare , ICML

PharmaSources Customer Service